| Literature DB >> 31991808 |
Peng Sun1,2, Dong-Hua Cao1,2, Yi-Dian Xiao3,4, Zong-Yi Zhang1,2, Jia-Nan Wang1,2, Xiao-Cui Shi1,2, Chun-Fen Xiao1, Hua-Bin Hu1, You-Kai Xu1.
Abstract
Four new diterpenoids, named aspidoptoids A-D (1-4), together with two known analogues (5-6) were isolated from Aspidopterys obcordata vine. Aspidoptoids A-B (1-2) are the first examples of phenylethylene-bearing 20-nor-diterpenoids of which aspidoptoid B (2) possesses a rare 3,10-oxybridge. Their structures and absolute configuration were determined by extensive spectroscopic analyses (IR, HRESIMS, 1D and 2D NMR) and electronic circular dichroism (ECD) calculation. In addition, all the isolates were evaluated for their cytotoxic activities and inhibitory effects on the nitric oxide (NO) production.Entities:
Keywords: Aspidopterys obcordata; Malpighiaceae; anti-inflammatory activity; cytotoxic activity; norditerpeniod
Year: 2020 PMID: 31991808 PMCID: PMC7036900 DOI: 10.3390/molecules25030529
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The structures of compounds 1–6.
1H (600 MHz) NMR data for compounds 1–4 in CDCl3.
| No. | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 1 | 6.18, t (3.1) | 4.32, dd (10.3, 3.6) | 6.83, d (2.7) | 3.05, d (12.3) |
| 1 | 2.63, d (12.3) | |||
| 2 | 2.16, ddd (10.2, 6.5, 3.1) | 1.81, dd (13.2, 3.6) | ||
| 2 | 2.47, m | 2.30, m | ||
| 3 | 3.60, overlapped | 3.86, d (5.9) | 4.09, s | 3.97, s |
| 5 | 2.02, m | 2.38, dd (13.6, 4.8) | 3.15, ddd (13.5, 5.2, 2.7) | 1.96, dd (12.2, 2.0) |
| 6 | 1.37, ddd (26.3, 7.2, 2.9) | 1.28, m | 2.73, dd (16.4, 13.5) | 1.75, ddd (25.2, 12.2, 6.0) |
| 6 | 2.03, m | 1.78, m | 2.88, dd (16.4, 5.2) | 2.01, m |
| 7 | 2.87, ddd (16.5, 4.1, 2.9) | 2.88, m | 2.84, dd (17.3, 6.0) | |
| 7 | 2.5, m | 2.30, m | 2.67, m | |
| 11 | 7.03, s | 6.85, s | 6.80, s | 6.54, s |
| 15 | 6.61, dd (17.9, 11.4) | 6.66, dd (18.0, 11.4) | 6.58, dd (18.0, 11.4) | |
| 16 | 5.55, dd (11.4, 2.0) | 5.57, dd (11.4, 2.0) | 5.56, dd (11.4, 2.0) | |
| 16 | 5.17, dd (17.9, 2.0) | 5.19, dd (18.0, 2.0) | 5.18, dd (18.0, 2.0) | |
| 17 | 2.19, s | 2.19, s | 2.13, s | 2.19, s |
| 18 | 0.77, s | 1.02, s | 0.85, s | 0.78, s |
| 19 | 1.11, s | 1.20, s | 1.29, s | 1.25, s |
| 20 | 1.18, s | |||
| OMe-12 | 3.93, s | |||
| OH-3 | 3.47, s | |||
| OH-14 | 12.77, s |
13C (150 MHz) NMR data for compounds 1–4 in CDCl3.
| No. | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
|
|
|
|
| |
| 1 | 116.5 | 79.9 | 119.6 | 52.1 |
| 2 | 32.3 | 34.2 | 199.1 | 210.7 |
| 3 | 74.9 | 86.9 | 79.7 | 82.8 |
| 4 | 37.2 | 44.6 | 41.3 | 44.9 |
| 5 | 46.2 | 43.8 | 46.0 | 48.8 |
| 6 | 24.0 | 22.7 | 37.4 | 19.2 |
| 7 | 28.9 | 28.3 | 201.4 | 29.1 |
| 8 | 127.3 | 122.4 | 110.5 | 125.1 |
| 9 | 132.9 | 130.9 | 136.0 | 145.4 |
| 10 | 134.5 | 87.1 | 153.6 | 43.8 |
| 11 | 108.3 | 112.1 | 99.8 | 109.4 |
| 12 | 152.1 | 152.4 | 163.6 | 152.5 |
| 13 | 121.3 | 132.7 | 117.6 | 120.2 |
| 14 | 139.5 | 138.8 | 162.1 | 139.7 |
| 15 | 135.3 | 135.1 | 135.3 | |
| 16 | 120.1 | 120.5 | 120.1 | |
| 17 | 13.1 | 13.0 | 8.1 | 13.0 |
| 18 | 13.4 | 24.2 | 14.1 | 16.4 |
| 19 | 24.4 | 24.5 | 24.4 | 29.3 |
| 20 | 26.1 | |||
| OMe-12 | 56.0 |
Figure 2Selected 1H-1H COSY and HMBC correlations of compounds 1–4.
Figure 3Key ROESY correlations of compounds 1–4.
Figure 4Experimental and calculated ECD spectra of compounds 1−4.
Scheme 1Plausible biosynthetic pathways of compounds 1–4.
NO inhibitory effects of compounds 1–6.
| Compound | Concentration (μΜ) | NO Inhibition Rate (%) |
|---|---|---|
|
| 50 | −5.94 ± 2.27 |
|
| 50 | −0.56 ± 1.09 |
|
| 50 | −3.50 ± 1.60 |
|
| 50 | −7.78 ± 1.50 |
|
| 50 | 31.54 ± 1.55 |
|
| 50 | −11.45 ± 1.93 |
| 50 | 51.23 ± 0.65 |
a Positive control.